Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

UroGen Pharma (URGN) Debt Ratio (2022 - 2025)

UroGen Pharma (URGN) has disclosed Debt Ratio for 4 consecutive years, with 0.61 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Debt Ratio rose 43.09% year-over-year to 0.61, compared with a TTM value of 0.61 through Dec 2025, up 43.09%, and an annual FY2025 reading of 0.61, up 43.09% over the prior year.
  • Debt Ratio was 0.61 for Q4 2025 at UroGen Pharma, down from 0.66 in the prior quarter.
  • Across five years, Debt Ratio topped out at 1.03 in Q2 2023 and bottomed at 0.35 in Q2 2024.
  • Average Debt Ratio over 4 years is 0.57, with a median of 0.53 recorded in 2023.
  • The sharpest move saw Debt Ratio skyrocketed 111.58% in 2023, then crashed 66.33% in 2024.
  • Year by year, Debt Ratio stood at 0.72 in 2022, then dropped by 23.15% to 0.55 in 2023, then decreased by 22.91% to 0.43 in 2024, then soared by 43.09% to 0.61 in 2025.
  • Business Quant data shows Debt Ratio for URGN at 0.61 in Q4 2025, 0.66 in Q3 2025, and 0.59 in Q2 2025.